Fingerprint
Dive into the research topics of 'AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Bowen Yan, David Claxton, Suming Huang, Yi Qiu
- Department of Medicine
- Division of Hematology and Oncology
- Penn State Cancer Institute
- Cancer Institute, Next-Generation Therapies
- Department of Pediatrics
- Division of Hematology and Oncology
- Department of Pharmacology
- Cancer Institute, Mechanisms of Carcinogenesis
- Department of Cellular and Molecular Physiology
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations